Profile | GDS5420 / 203854_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 101.52 | 42 |
GSM1296119 | B_lesional_pre-dose | 265.86 | 57 |
GSM1296076 | C_lesional_pre-dose | 166.04 | 51 |
GSM1296092 | D_lesional_pre-dose | 149.41 | 50 |
GSM1296103 | E_lesional_pre-dose | 150.1 | 48 |
GSM1296078 | F_lesional_pre-dose | 164.16 | 51 |
GSM1296107 | G_lesional_pre-dose | 183.39 | 50 |
GSM1296109 | H_lesional_pre-dose | 275.67 | 57 |
GSM1296080 | I_lesional_pre-dose | 259.13 | 57 |
GSM1296090 | J_lesional_pre-dose | 239.57 | 56 |
GSM1296074 | K_lesional_pre-dose | 180.66 | 53 |
GSM1296111 | L_lesional_pre-dose | 142.4 | 45 |
GSM1296099 | M_lesional_pre-dose | 304.26 | 59 |
GSM1296086 | O_lesional_pre-dose | 171.23 | 51 |
GSM1296117 | P_lesional_pre-dose | 252.27 | 55 |
GSM1296113 | Q_lesional_pre-dose | 207.24 | 51 |
GSM1296096 | R_lesional_pre-dose | 163.54 | 50 |
GSM1296105 | S_lesional_pre-dose | 376.01 | 62 |
GSM1296098 | T_lesional_pre-dose | 71.39 | 35 |
GSM1296101 | U_lesional_pre-dose | 172.16 | 49 |
GSM1296121 | V_lesional_pre-dose | 264.14 | 57 |
GSM1296088 | W_lesional_pre-dose | 300.62 | 59 |
GSM1296082 | X_lesional_pre-dose | 119.3 | 46 |
GSM1296115 | Y_lesional_pre-dose | 180.98 | 50 |
GSM1296084 | Z_lesional_pre-dose | 154.29 | 48 |
GSM1296072 | B_lesional_day8 | 314.49 | 59 |
GSM1296069 | L_lesional_day8 | 404.39 | 63 |
GSM1296071 | P_lesional_day8 | 338.57 | 60 |
GSM1296070 | Y_lesional_day8 | 186.82 | 49 |
GSM1296073 | V_lesional_day8 | 189.6 | 52 |
GSM1296034 | A_lesional_day15 | 234.15 | 54 |
GSM1296041 | G_lesional_day15 | 158.61 | 48 |
GSM1296035 | R_lesional_day15 | 215.94 | 54 |
GSM1296038 | U_lesional_day15 | 295.58 | 59 |
GSM1296047 | B_lesional_day15 | 381.18 | 63 |
GSM1296039 | E_lesional_day15 | 200.86 | 53 |
GSM1296042 | H_lesional_day15 | 329.99 | 60 |
GSM1296043 | L_lesional_day15 | 257.68 | 55 |
GSM1296037 | M_lesional_day15 | 298.66 | 58 |
GSM1296046 | P_lesional_day15 | 229.11 | 53 |
GSM1296044 | Q_lesional_day15 | 186.63 | 49 |
GSM1296045 | Y_lesional_day15 | 182.88 | 49 |
GSM1296025 | C_lesional_day15 | 506.54 | 68 |
GSM1296033 | D_lesional_day15 | 225.55 | 54 |
GSM1296027 | I_lesional_day15 | 428.47 | 66 |
GSM1296032 | J_lesional_day15 | 363.33 | 62 |
GSM1296024 | K_lesional_day15 | 619.79 | 71 |
GSM1296031 | W_lesional_day15 | 545.05 | 69 |
GSM1296028 | X_lesional_day15 | 255.05 | 57 |
GSM1296029 | Z_lesional_day15 | 480.23 | 67 |
GSM1296026 | F_lesional_day15 | 414.26 | 65 |
GSM1296030 | O_lesional_day15 | 212.34 | 55 |
GSM1296040 | S_lesional_day15 | 216.41 | 53 |
GSM1296036 | T_lesional_day15 | 304.41 | 58 |
GSM1296048 | V_lesional_day15 | 301.29 | 59 |
GSM1296059 | A_lesional_day43 | 174.77 | 51 |
GSM1296066 | G_lesional_day43 | 259.38 | 56 |
GSM1296060 | R_lesional_day43 | 339.46 | 61 |
GSM1296063 | U_lesional_day43 | 199.8 | 52 |
GSM1296064 | E_lesional_day43 | 189.85 | 52 |
GSM1296067 | H_lesional_day43 | 689.02 | 73 |
GSM1296062 | M_lesional_day43 | 234.29 | 54 |
GSM1296068 | Q_lesional_day43 | 335.16 | 60 |
GSM1296050 | C_lesional_day43 | 552.74 | 70 |
GSM1296057 | D_lesional_day43 | 318.09 | 60 |
GSM1296052 | I_lesional_day43 | 430.47 | 66 |
GSM1296054 | J_lesional_day43 | 423.7 | 64 |
GSM1296049 | K_lesional_day43 | 652 | 72 |
GSM1296055 | W_lesional_day43 | 496.35 | 67 |
GSM1296053 | X_lesional_day43 | 354.07 | 62 |
GSM1296058 | Z_lesional_day43 | 309.79 | 60 |
GSM1296051 | F_lesional_day43 | 363.47 | 63 |
GSM1296056 | O_lesional_day43 | 245.04 | 57 |
GSM1296065 | S_lesional_day43 | 374.39 | 63 |
GSM1296061 | T_lesional_day43 | 323.83 | 60 |
GSM1296095 | A_non-lesional_pre-dose | 120.01 | 45 |
GSM1296120 | B_non-lesional_pre-dose | 301.95 | 59 |
GSM1296077 | C_non-lesional_pre-dose | 342.4 | 62 |
GSM1296093 | D_non-lesional_pre-dose | 228.68 | 54 |
GSM1296104 | E_non-lesional_pre-dose | 167.78 | 49 |
GSM1296079 | F_non-lesional_pre-dose | 512.75 | 68 |
GSM1296108 | G_non-lesional_pre-dose | 298.48 | 58 |
GSM1296110 | H_non-lesional_pre-dose | 318.36 | 59 |
GSM1296081 | I_non-lesional_pre-dose | 226.11 | 55 |
GSM1296091 | J_non-lesional_pre-dose | 182.69 | 52 |
GSM1296075 | K_non-lesional_pre-dose | 327.92 | 62 |
GSM1296112 | L_non-lesional_pre-dose | 266.91 | 55 |
GSM1296100 | M_non-lesional_pre-dose | 160.62 | 48 |
GSM1296087 | O_non-lesional_pre-dose | 294.05 | 60 |
GSM1296118 | P_non-lesional_pre-dose | 302.6 | 58 |
GSM1296114 | Q_non-lesional_pre-dose | 243.28 | 54 |
GSM1296097 | R_non-lesional_pre-dose | 193.09 | 52 |
GSM1296106 | S_non-lesional_pre-dose | 297.85 | 58 |
GSM1296102 | U_non-lesional_pre-dose | 254.38 | 55 |
GSM1296122 | V_non-lesional_pre-dose | 769.4 | 75 |
GSM1296089 | W_non-lesional_pre-dose | 283.18 | 57 |
GSM1296083 | X_non-lesional_pre-dose | 350.94 | 61 |
GSM1296116 | Y_non-lesional_pre-dose | 185.74 | 49 |
GSM1296085 | Z_non-lesional_pre-dose | 283.75 | 58 |